CLARUS THERAPEUTICS HOLDINGS, INC. Interest Expense
CLARUS THERAPEUTICS HOLDINGS, INC. reported Interest Expense of $2.02 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for the quarter ending 2022-06-30 was $2.02M, a 58.58% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for the quarter ending 2022-03-31 was $1.97M, a 57.65% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for the quarter ending 2021-12-31 was $1.93M, a 58.06% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for the quarter ending 2021-09-30 was $4.45M, a 3.64% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for fiscal 2021 was $15.89M, a 3.25% increase from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. interest expense for fiscal 2020 was $15.39M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $2.02M 10-Q · filed 2022-08-19 | $3.98M 10-Q · filed 2022-08-19 | $5.92M derived: sum of 3 quarters · filed 2022-08-19 | $10.36M derived: sum of 4 quarters · filed 2022-08-19 |
| 2022-03-31 | $1.97M 10-Q · filed 2022-05-16 | $3.90M derived: sum of 2 quarters · filed 2022-05-16 | $8.34M derived: sum of 3 quarters · filed 2022-05-16 | $13.22M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $6.38M derived: sum of 2 quarters · filed 2022-03-31 | $11.26M derived: sum of 3 quarters · filed 2022-08-19 | $15.89M 10-K · filed 2022-03-31 |
| 2021-09-30 | $4.45M 10-Q · filed 2021-11-19 | $9.32M derived: sum of 2 quarters · filed 2022-08-19 | $13.96M 10-Q · filed 2021-11-19 | $18.57M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-06-30 | $4.88M 10-Q · filed 2022-08-19 | $9.52M 10-Q · filed 2022-08-19 | $14.12M derived: sum of 3 quarters · filed 2022-08-19 | $18.41M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $4.64M 10-Q · filed 2022-05-16 | $9.24M derived: sum of 2 quarters · filed 2022-05-16 | $13.54M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $8.89M derived: sum of 2 quarters · filed 2022-03-31 | $15.39M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $4.29M 10-Q · filed 2021-11-19 | $10.79M 10-Q · filed 2021-11-19 |